Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Merck and Pfizer claim second FDA nod for cancer drug Bavencio

Merck and Pfizer claim second FDA nod for cancer drug Bavencio Merck KGaA and Pfizer's immuno-oncology drug Bavencio has been approved by the FDA for bladder cancer, the second for the new drug in less than two months. ... Also in the offing is Merck &Co's PD-1 inhibitor Keytruda (pembrolizumab) which has been filed

Merck takes on Roche with first-line bladder OK for Keytruda

Merck takes on Roche with first-line bladder OK for Keytruda Keytruda joins Roche's Tecentriq (atezolizumab) in the first-line UC treatment setting, and Tecentriq and three other checkpoint inhibitors - Bristol-Myers Squibb's Opdivo (nivolumab), Merck KGaA/Pfizer's Bavencio ... The drug made $1.4bn for Merck last

IFPMA appoints Fumie Griego as assistant director general

IFPMA appoints Fumie Griego as assistant director general She joins the global pharma association from Merck KGaA. Global pharma association the International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) has appointed Femie Griego to be its new assistant director general. ... She joins from

Tecentriq bladder cancer approval in doubt after trial failure

Tecentriq bladder cancer approval in doubt after trial failure Now, Roche is facing the possibility that its conditional approval could be revoked at a time when other drugs in the class - BMS' Opdivo (nivolumab), Merck KGaA/Pfizer's Bavencio (avelumab), ... AstraZeneca's Imfinzi (durvalumab) - have already claimed

Kymab appoints its first chief medical officer

Kymab appoints its first chief medical officer Prior to her time at Novartis, Quaratino worked for Merck Serono, where she was responsible for the clinical development of various immunomodulators.

[ Previous 5 results ] 16 17 18 19 20 21 22 23 24 25 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...